The (bio) pharmaceutical and health sector is facing a new era of opportunity as it incorporates healthcare innovations and technologies in areas such as genomics, precision medicines, big data and connected health.
With issues of sustainability, an aging population and increasing levels of non-communicable diseases, the rapid acceleration of healthcare-related knowledge which fuses digital technologies with traditional science offers the potential for radical sectoral transformation and enhanced patient outcomes. This has led to an increasing focus on disease prevention and tailored therapies and technologies.
Students - please use your own personal email address here and not the one supplied by your school. For security reasons school emails block external messages.